Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Rank in Stocks #19087
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Share Price
$10.18
Last synced: 2023-03-01
Market Cap
$175.61M
Change (1 day)
-0.29%
Change (1 year)
0.00%
Country
US
Trade Ibere Pharmaceuticals (IBER)
EPS for Ibere Pharmaceuticals (IBER)
EPS as of 2026 TTM: 0
According to Ibere Pharmaceuticals latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Ibere Pharmaceuticals from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors